Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. [electronic resource]
Producer: 20161213Description: 381-91 p. digitalISSN:- 1432-1912
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Antioxidants -- pharmacology
- Apoptosis -- drug effects
- Benzoquinones -- pharmacology
- Diet, High-Fat
- Hepatitis -- drug therapy
- Inflammation Mediators -- metabolism
- Insulin Resistance
- Interleukin-10 -- metabolism
- Lipids -- blood
- Liver -- drug effects
- Liver Cirrhosis, Experimental -- metabolism
- Male
- Non-alcoholic Fatty Liver Disease -- drug therapy
- Oxidative Stress -- drug effects
- PPAR gamma -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Rats, Wistar
- Tumor Necrosis Factor-alpha -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.